Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 52

1.

Targeted sequencing of plasma cell-free DNA to predict response to PD1 inhibitors in advanced non-small cell lung cancer.

Guibert N, Jones G, Beeler JF, Plagnol V, Morris C, Mourlanette J, Delaunay M, Keller L, Rouquette I, Favre G, Pradines A, Mazieres J.

Lung Cancer. 2019 Sep 6;137:1-6. doi: 10.1016/j.lungcan.2019.09.005. [Epub ahead of print]

PMID:
31518912
2.

Exhaled nitric oxide in chronic cough: A good tool in a multi-step approach.

Lamon T, Didier A, Brouquières D, Escamilla R, Dupuis M, Guibert N, Leseux L, Guilleminault L.

Respir Med Res. 2019 Apr 20;76:4-9. doi: 10.1016/j.resmer.2019.04.005. [Epub ahead of print]

PMID:
31254946
3.

[Management of non-small cell lung cancer patients harboring activating mutations and CNS progression].

Rouviere D, Veillon R, Chaltiel L, Simonneau Y, Filleron T, Milia J, Guibert N, Melloni B, Raherison C, Didier A, Mazieres J.

Rev Mal Respir. 2019 May;36(5):583-590. doi: 10.1016/j.rmr.2019.04.003. Epub 2019 Jun 13. French.

PMID:
31202602
4.

When to Consider Immune Checkpoint Inhibitors in Oncogene-Driven Non-Small Cell Lung Cancer?

Mhanna L, Guibert N, Milia J, Mazieres J.

Curr Treat Options Oncol. 2019 Jun 6;20(7):60. doi: 10.1007/s11864-019-0652-3. Review.

5.

Extent of positive surgical margins following radical prostatectomy: impact on biochemical recurrence with long-term follow-up.

Koskas Y, Lannes F, Branger N, Giusiano S, Guibert N, Pignot G, Walz J, Rossi D, Bastide C.

BMC Urol. 2019 May 15;19(1):37. doi: 10.1186/s12894-019-0470-8.

6.

Treatment of complex airway stenoses using patient-specific 3D-engineered stents: a proof-of-concept study.

Guibert N, Didier A, Moreno B, Lepage B, Leyx P, Plat G, Mhanna L, Murris M, Mazières J, Hermant C.

Thorax. 2019 Aug;74(8):810-813. doi: 10.1136/thoraxjnl-2018-212732. Epub 2019 Apr 3.

PMID:
30944151
7.

Non-invasive assessment of tumor PD-L1 status with circulating tumor cells.

Ulrich BC, Guibert N.

Ann Transl Med. 2018 Nov;6(Suppl 1):S48. doi: 10.21037/atm.2018.10.09. No abstract available.

8.

The Society for Translational Medicine: indications and methods of percutaneous transthoracic needle biopsy for diagnosis of lung cancer.

Zhou Q, Dong J, He J, Liu D, Tian DH, Gao S, Li S, Liu L, He J, Huang Y, Xu S, Mao W, Tan Q, Chen C, Li X, Zhang Z, Jiang G, Xu L, Zhang L, Fu J, Li H, Wang Q, Tan L, Li D, Zhou Q, Fu X, Jiang Z, Chen H, Fang W, Zhang X, Li Y, Tong T, Yu Z, Liu Y, Zhi X, Yan T, Zhang X, Casal RF, Pompeo E, Carretta A, Riquet M, Rena O, Falcoz PE, Saji H, Khan AZ, Danguilan JL, Gonzalez-Rivas D, Guibert N, Zhu C, Shen J.

J Thorac Dis. 2018 Sep;10(9):5538-5544. doi: 10.21037/jtd.2018.09.28. Review. No abstract available.

9.

Early Circulating Tumour DNA Variations Predict Tumour Response in Melanoma Patients Treated with Immunotherapy.

Keller L, Guibert N, Casanova A, Brayer S, Farella M, Delaunay M, Gilhodes J, Martin E, Balagué G, Favre G, Pradines A, Meyer N.

Acta Derm Venereol. 2019 Feb 1;99(2):206-210. doi: 10.2340/00015555-3080.

10.

Immunotherapy efficacy and gender: discovery in precision medicine.

Ulrich BC, Guibert N.

Transl Lung Cancer Res. 2018 Sep;7(Suppl 3):S211-S213. doi: 10.21037/tlcr.2018.08.05. No abstract available.

11.

Pre-surgical medical treatment, a major prognostic factor for long-term remission in acromegaly.

Albarel F, Castinetti F, Morange I, Guibert N, Graillon T, Dufour H, Brue T.

Pituitary. 2018 Dec;21(6):615-623. doi: 10.1007/s11102-018-0916-0.

PMID:
30367444
12.

Liquid biopsy of fine-needle aspiration supernatant for lung cancer genotyping.

Guibert N, Tsukada H, Hwang DH, Chambers E, Cibas ES, Bale T, Supplee J, Ulrich B, Sholl LM, Paweletz CP, Oxnard GR.

Lung Cancer. 2018 Aug;122:72-75. doi: 10.1016/j.lungcan.2018.05.024. Epub 2018 May 25.

PMID:
30032849
13.

Effect of mutant variants of the KRAS gene on PD-L1 expression and on the immune microenvironment and association with clinical outcome in lung adenocarcinoma patients.

Falk AT, Yazbeck N, Guibert N, Chamorey E, Paquet A, Ribeyre L, Bence C, Zahaf K, Leroy S, Marquette CH, Cohen C, Mograbi B, Mazières J, Hofman V, Brest P, Hofman P, Ilié M.

Lung Cancer. 2018 Jul;121:70-75. doi: 10.1016/j.lungcan.2018.05.009. Epub 2018 May 26.

PMID:
29858030
14.

PD-L1 expression in circulating tumor cells of advanced non-small cell lung cancer patients treated with nivolumab.

Guibert N, Delaunay M, Lusque A, Boubekeur N, Rouquette I, Clermont E, Mourlanette J, Gouin S, Dormoy I, Favre G, Mazieres J, Pradines A.

Lung Cancer. 2018 Jun;120:108-112. doi: 10.1016/j.lungcan.2018.04.001. Epub 2018 Apr 3.

PMID:
29748004
15.

False-Positive Plasma Genotyping Due to Clonal Hematopoiesis.

Hu Y, Ulrich BC, Supplee J, Kuang Y, Lizotte PH, Feeney NB, Guibert NM, Awad MM, Wong KK, Jänne PA, Paweletz CP, Oxnard GR.

Clin Cancer Res. 2018 Sep 15;24(18):4437-4443. doi: 10.1158/1078-0432.CCR-18-0143. Epub 2018 Mar 22.

16.

Integration of 3D printing and additive manufacturing in the interventional pulmonologist's toolbox.

Guibert N, Mhanna L, Didier A, Moreno B, Leyx P, Plat G, Mazieres J, Hermant C.

Respir Med. 2018 Jan;134:139-142. doi: 10.1016/j.rmed.2017.11.019. Epub 2017 Dec 2. Review.

PMID:
29413501
17.

Amplicon-based next-generation sequencing of plasma cell-free DNA for detection of driver and resistance mutations in advanced non-small cell lung cancer.

Guibert N, Hu Y, Feeney N, Kuang Y, Plagnol V, Jones G, Howarth K, Beeler JF, Paweletz CP, Oxnard GR.

Ann Oncol. 2018 Apr 1;29(4):1049-1055. doi: 10.1093/annonc/mdy005.

18.

Towards a comprehensive framework for cell-free DNA analysis: lessons from TRACERx.

Ulrich BC, Guibert N.

Ann Transl Med. 2017 Nov;5(21):428. doi: 10.21037/atm.2017.08.12. No abstract available.

19.

[Use of endobronchial ultrasound in the management of cryptogenic haemoptysis].

Mhanna L, Noel-Savina E, Pontier S, Jaffro M, Guibert N, Hermant C, Plat G, Didier A.

Rev Mal Respir. 2017 Sep;34(7):770-773. doi: 10.1016/j.rmr.2016.12.003. Epub 2017 Sep 1. French.

PMID:
28867308
20.

Endobronchial Protrusion of an Amplatzer Plug After Embolization of the Pulmonary Artery.

Mhanna L, Jaffro M, Mazieres J, Guibert N.

J Bronchology Interv Pulmonol. 2017 Jul;24(3):33-34. doi: 10.1097/LBR.0000000000000376. No abstract available.

PMID:
28696969
21.

Monitoring of KRAS-mutated ctDNA to discriminate pseudo-progression from true progression during anti-PD-1 treatment of lung adenocarcinoma.

Guibert N, Mazieres J, Delaunay M, Casanova A, Farella M, Keller L, Favre G, Pradines A.

Oncotarget. 2017 Jun 6;8(23):38056-38060. doi: 10.18632/oncotarget.16935.

22.

Molecular biomarkers for lung adenocarcinoma.

Calvayrac O, Pradines A, Pons E, Mazières J, Guibert N.

Eur Respir J. 2017 Apr 5;49(4). pii: 1601734. doi: 10.1183/13993003.01734-2016. Print 2017 Apr. Review.

23.

Stenting of Complex Malignant Central-Airway Obstruction Guided by a Three-Dimensional Printed Model Of The Airways.

Guibert N, Moreno B, Plat G, Didier A, Mazieres J, Hermant C.

Ann Thorac Surg. 2017 Apr;103(4):e357-e359. doi: 10.1016/j.athoracsur.2016.09.082.

PMID:
28359498
24.

Usefulness of 3D Printing to Manage Complex Tracheal Stenosis.

Guibert N, Moreno B, Hermant C.

J Bronchology Interv Pulmonol. 2017 Apr;24(2):e27-e29. doi: 10.1097/LBR.0000000000000380. No abstract available.

PMID:
28323743
25.

Treatment of Post-transplant Complex Airway Stenosis with a Three-Dimensional, Computer-assisted Customized Airway Stent.

Guibert N, Didier A, Moreno B, Mhanna L, Brouchet L, Plat G, Hermant C, Mazieres J.

Am J Respir Crit Care Med. 2017 Apr 1;195(7):e31-e33. doi: 10.1164/rccm.201611-2361IM. No abstract available.

PMID:
28207282
26.

Characteristics and Outcomes of Patients with Lung Cancer Harboring Multiple Molecular Alterations: Results from the IFCT Study Biomarkers France.

Guibert N, Barlesi F, Descourt R, Léna H, Besse B, Beau-Faller M, Mosser J, Pichon E, Merlio JP, Ouafik L, Guichard F, Mastroianni B, Moreau L, Wdowik A, Sabourin JC, Lemoine A, Missy P, Langlais A, Moro-Sibilot D, Mazières J.

J Thorac Oncol. 2017 Jun;12(6):963-973. doi: 10.1016/j.jtho.2017.02.001. Epub 2017 Feb 9.

27.

Techniques of endoscopic airway tumor treatment.

Guibert N, Mhanna L, Droneau S, Plat G, Didier A, Mazieres J, Hermant C.

J Thorac Dis. 2016 Nov;8(11):3343-3360. doi: 10.21037/jtd.2016.11.49. Review.

28.

The RAS-related GTPase RHOB confers resistance to EGFR-tyrosine kinase inhibitors in non-small-cell lung cancer via an AKT-dependent mechanism.

Calvayrac O, Mazières J, Figarol S, Marty-Detraves C, Raymond-Letron I, Bousquet E, Farella M, Clermont-Taranchon E, Milia J, Rouquette I, Guibert N, Lusque A, Cadranel J, Mathiot N, Savina A, Pradines A, Favre G.

EMBO Mol Med. 2017 Feb;9(2):238-250. doi: 10.15252/emmm.201606646.

29.

Bronchoscopic Multimodal Management of Tracheal Neurofibroma.

Rabeau A, Mazieres J, Hermant C, Projetti F, Didier A, Guibert N.

J Bronchology Interv Pulmonol. 2016 Oct;23(4):340-342.

PMID:
26496086
30.

Monitoring KRAS mutations in circulating DNA and tumor cells using digital droplet PCR during treatment of KRAS-mutated lung adenocarcinoma.

Guibert N, Pradines A, Farella M, Casanova A, Gouin S, Keller L, Favre G, Mazieres J.

Lung Cancer. 2016 Oct;100:1-4. doi: 10.1016/j.lungcan.2016.07.021. Epub 2016 Jul 22.

PMID:
27597273
31.

A pancreatic ductal adenocarcinoma subpopulation is sensitive to FK866, an inhibitor of NAMPT.

Barraud M, Garnier J, Loncle C, Gayet O, Lequeue C, Vasseur S, Bian B, Duconseil P, Gilabert M, Bigonnet M, Maignan A, Moutardier V, Garcia S, Turrini O, Delpero JR, Giovannini M, Grandval P, Gasmi M, Ouaissi M, Secq V, Poizat F, Guibert N, Iovanna J, Dusetti N.

Oncotarget. 2016 Aug 16;7(33):53783-53796. doi: 10.18632/oncotarget.10776.

32.

Erratum à l'article « Controverse des estroprogestatifs de 3e et 4e génération : quelle influence sur le comportement des femmes ? » [Presse Med. 45/4 (2016) e68-78].

Torres L, Frapard C, Daumas A, Guibert N, Lagouanelle-Simeoni MC, Rakoto JC, Villani P, Sambuc R.

Presse Med. 2016 Jul-Aug;45(7-8P1):717. doi: 10.1016/j.lpm.2016.06.001. Epub 2016 Jun 28. French. No abstract available.

PMID:
27371356
33.

[Molecular epidemiology of the lung cancer].

Guibert N, Milia JD, Mazieres J.

Rev Mal Respir. 2016 Oct;33(8):675-681. doi: 10.1016/j.rmr.2016.01.007. Epub 2016 Jun 3. Review. French.

PMID:
27266901
34.

Detection and Monitoring of the BRAF Mutation in Circulating Tumor Cells and Circulating Tumor DNA in BRAF-Mutated Lung Adenocarcinoma.

Guibert N, Pradines A, Casanova A, Farella M, Keller L, Soria JC, Favre G, Mazières J.

J Thorac Oncol. 2016 Sep;11(9):e109-12. doi: 10.1016/j.jtho.2016.05.001. Epub 2016 May 7. No abstract available.

35.

The Relocation of a Health Care Department's Impact on Staff: A Cross-Sectional Survey.

Bellagamba G, Michel L, Alcaraz-Mor R, Giovannetti L, Merigot L, Lagouanelle MC, Guibert N, Lehucher-Michel MP.

J Occup Environ Med. 2016 Apr;58(4):364-9. doi: 10.1097/JOM.0000000000000664. Erratum in: J Occup Environ Med. 2017 Apr;59(4):e73.

PMID:
27058476
36.

[3rd and 4th generation estroprogestatives French controversy: What effect on women's behavior?].

Torres L, Frapard C, Daumas A, Guibert N, Lagouanelle-Simeoni MC, Rakoto JC, Villani P, Sambuc R.

Presse Med. 2016 Apr;45(4 Pt 1):e68-78. doi: 10.1016/j.lpm.2015.10.024. Epub 2016 Mar 24. French.

PMID:
27016851
37.

Tracheal Glomangioleiomyoma Treated by Multimodal Interventional Bronchoscopy.

Guibert N, Mazieres J, Didier A, Porte SJ, Projetti F, Hermant C.

Ann Thorac Surg. 2016 Apr;101(4):1591-4. doi: 10.1016/j.athoracsur.2015.05.128.

PMID:
27000586
38.

Nivolumab for treating non-small cell lung cancer.

Guibert N, Mazières J.

Expert Opin Biol Ther. 2015;15(12):1789-97. doi: 10.1517/14712598.2015.1114097. Epub 2015 Nov 16. Review.

PMID:
26574148
39.

[KRAS and bronchial adenocarcinoma. Between disappointments and hopes].

Guibert N, Ilie M, Léna H, Didier A, Hofman P, Mazieres J.

Rev Mal Respir. 2016 Feb;33(2):156-64. doi: 10.1016/j.rmr.2015.05.012. Epub 2015 Nov 6. Review. French.

PMID:
26520779
40.

Integration of interventional bronchoscopy in the management of lung cancer.

Guibert N, Mazieres J, Marquette CH, Rouviere D, Didier A, Hermant C.

Eur Respir Rev. 2015 Sep;24(137):378-91. doi: 10.1183/16000617.00010014. Review.

41.

[New targets and new drugs in thoracic oncology].

Rouviere D, Bousquet E, Pons E, Milia JD, Guibert N, Mazieres J.

Rev Mal Respir. 2015 Oct;32(8):867-76. doi: 10.1016/j.rmr.2015.02.091. Epub 2015 Jun 12. Review. French.

PMID:
26076869
42.

KRAS Mutations in Lung Adenocarcinoma: Molecular and Epidemiological Characteristics, Methods for Detection, and Therapeutic Strategy Perspectives.

Guibert N, Ilie M, Long E, Hofman V, Bouhlel L, Brest P, Mograbi B, Marquette CH, Didier A, Mazieres J, Hofman P.

Curr Mol Med. 2015;15(5):418-32. Review.

PMID:
25941815
43.

Targeting the immune system to treat lung cancer: rationale and clinical experience.

Guibert N, Delaunay M, Mazières J.

Ther Adv Respir Dis. 2015 Jun;9(3):105-20. doi: 10.1177/1753465815578349. Epub 2015 Mar 31. Review.

PMID:
25827132
44.

Assessment of myocardial partition coefficient of gadolinium (λ) in dilated cardiomyopathy and its impact on segmental and global systolic function.

Jacquier A, Kallifatidis A, Guibert N, Giorgi R, Falque C, Thuny F, Croisille P, Clarysse P, Maurel B, Flavian A, Gaubert JY, Moulin G, Habib G.

J Magn Reson Imaging. 2014 Dec;40(6):1336-41. doi: 10.1002/jmri.24515. Epub 2013 Nov 25.

PMID:
24989685
45.

Detection of circulating tumor cells from lung cancer patients in the era of targeted therapy: promises, drawbacks and pitfalls.

Hofman V, Ilie M, Long E, Guibert N, Selva E, Washetine K, Mograbi B, Mouroux J, Vénissac N, Reverso-Meinietti J, Milano G, Mazières J, Marquette CH, Paterlini-Bréchot P, Hofman P.

Curr Mol Med. 2014 May;14(4):440-56. Review.

PMID:
24730524
46.

Prognostic factors associated with interventional bronchoscopy in lung cancer.

Guibert N, Mazieres J, Lepage B, Plat G, Didier A, Hermant C.

Ann Thorac Surg. 2014 Jan;97(1):253-9. doi: 10.1016/j.athoracsur.2013.07.118. Epub 2013 Oct 3.

PMID:
24094520
47.

Specificities of lung adenocarcinoma in women who have never smoked.

Mazières J, Rouquette I, Lepage B, Milia J, Brouchet L, Guibert N, Beau-Faller M, Validire P, Hofman P, Fouret P.

J Thorac Oncol. 2013 Jul;8(7):923-9. doi: 10.1097/JTO.0b013e3182904dfb.

48.

[Increase of mortality associated with emergency relocation of elderly nursing homes residents following flooding in the Var district, France, 2010].

Mantey K, Coccoz F, Boulogne O, Torrents R, Guibert N, Six C, Malfait P.

Geriatr Psychol Neuropsychiatr Vieil. 2012 Dec;10(4):373-82. doi: 10.1684/pnv.2012.0374. French.

PMID:
23250017
49.

Bronchial colonisation in patients with lung cancer: a prospective study.

Laroumagne S, Lepage B, Hermant C, Plat G, Phelippeau M, Bigay-Game L, Lozano S, Guibert N, Segonds C, Mallard V, Augustin N, Didier A, Mazieres J.

Eur Respir J. 2013 Jul;42(1):220-9. doi: 10.1183/09031936.00062212. Epub 2012 Oct 25.

50.

Thymoma and solid-organ transplantation.

Guibert N, Brouchet L, Rouquette I, Didier A, Rostaing L, Kamar N, Mazieres J.

Lung Cancer. 2012 Jul;77(1):232-4. doi: 10.1016/j.lungcan.2012.03.014. Epub 2012 Apr 7.

PMID:
22487431

Supplemental Content

Loading ...
Support Center